The CTSI invests in new resources for the benefit of the research community, supporting the launch and transition to cost recovery for new core services that address unmet investigator needs and create opportunities for translational research. Active cores receive initial startup support. After they are established, these cores remain affiliated with the CTSI and receive additional support via CTSI promotion, referrals and voucher support for services as appropriate.
Broad expertise in the application of human-validated assessment measures of behavioral concomitants of disease or therapeutic interventions.
Services and training for induced Pluripotent Stem Cell (iPSC) derivation and related reprogramming technologies.
Clinician training through simulation in processes, drugs and devices in order to promote patient safety.
Collection, processing, storage and distribution services on remnant and prospective tissue samples.
Consultation and guidance in designing and performing genetics and pharmacogenetics studies, and targeted determination of genotypes on genomic DNA from biological samples.
Infrastructure and support to facilitate research and educational activities using Magnetic Resonance Imaging (MRI) technology, with particular emphasis on translational MRI research in humans.
Metabolomics services for clinical and basic science studies, including mass spectrometry, nuclear magnetic resonance and bioinformatics.
Services and expertise in bioanalytical drug metabolism and preclinical pharmacokinetics to help promising compounds bridge the gap between lab and market.